AstraZeneca : BioPharmaceuticals presentation
BioPharmaceuticals Ruud Dobber, EVP and President, BioPharmaceuticals Sharon Barr, EVP, BioPharmaceuticals R&D ...
Source: marketscreener.com
Stay updated with breaking news from Clinical Trials Appendix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioPharmaceuticals Ruud Dobber, EVP and President, BioPharmaceuticals Sharon Barr, EVP, BioPharmaceuticals R&D ...
Rare Disease Marc Dunoyer, CEO, Alexion and Chief Strategy Officer, AstraZeneca Gianluca Pirozzi, SVP, Head of Development and Safety, Alexion ...
Oncology and Haematology David Fredrickson, EVP, Oncology Business Susan Galbraith, EVP, Oncology R&D Cristian...
Strong growth and pipeline momentum with three new medicines approved since the third quarter ...